Precipio, Inc. (PRPO) Stock: Here’s Why It’s Headed For The Top


Precipio, Inc. (PRPO) is headed up in the market today. The stock, focused in the biotech sector, is presently priced at $0.30 after a move up of 8.50% so far in today’s session. As it relates to biotechnology stocks, there are several aspects that have the ability to cause movement in the market. One of the most common is news. Here are the most recent trending headlines surrounding PRPO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-15-19 09:15AM Precipio Announces 2018 Year-End Corporate Update Call for Shareholders
Apr-09-19 09:15AM Precipio Identifies Manufacturer for its IV-Cell Media
Apr-03-19 07:38AM Precipios HemeScreen Adopted by Methodist Health
Mar-27-19 07:47AM Precipio Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing
Mar-11-19 08:45AM Precipio CEO Issues Shareholder Update Letter

However, any time investors are making a decision with regard to investing, prospective investors should take a look at far more than news, especially in the highly speculative biotech space. Here’s what’s happening in regard to Precipio, Inc..

Recent Movement Out of PRPO

Although a move up on a single session, like the gain that we’re seeing from Precipio, Inc. might cause excitement in some investors, a single session gain alone shouldn’t be the reason for a decision to, or not to, buy a company’s stock. It’s always important to dig into trends experienced by the stock further out than a single session. In the case of PRPO, below are the trends that we have seen:

  • Weekly – In the past 7 days, PRPO has seen a change in value that amounts to 86.79%.
  • Monthly – The monthly performance from Precipio, Inc. comes to 80.76%.
  • Past Three Months – Throughout the past three months, the company has generated a return that works out to 7.69%
  • Past 6 Months – Over the past six months, we’ve seen a performance that works out to -12.50% from the company.
  • This Year So Far – Since the open of this year PRPO has produced a ROI of 81.82%.
  • Annually – Lastly, throughout the past full year, we’ve seen a change that comes to -42.81% from PRPO. Over this period of time, the stock has traded at a high of -55.32% and a low of 175.93%.

Crucial Ratios

Digging into a few ratios having to do with a company generally gives prospective traders an understanding of how risky and/or rewarding a pick may be. Below are some of the important ratios to look at when looking at PRPO.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors have a belief that the stock is headed for declines. In general, biotech stocks can have a higher short ratio. On the other hand, we tend to see a lot of short squeezes in the industry. Nonetheless, in regard to Precipio, Inc., it’s short ratio amounts to 0.21.

Quick & Current Ratios – The quick and current ratios are tools that are used to get an idea of the company’s liquidity. Basically, they measure If a company is able to pay its debts when they mature with only quick assets or current assets. In the biotechnology industry, many companies rely heavily on the continuation of investor support, these ratios can be bad. Nonetheless, some good picks in the biotechnology sector come with good quick and current ratios. As far as PRPO, the quick and current ratios add up to 0.10 and 0.10 respectively.  

Book To Share Value – The book to share value ratio compares the value of assets owned by the company to the price of shares. when it comes to Precipio, Inc., the book to share value ratio is 0.40.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the price of the company’s stock. Several early stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotechnology industry, this is an important ratio to think about. In this case, the cash to share value ratio works out to 0.00.

Analyst Opinions Of Precipio, Inc.

Although it’s rarely a good idea to avoid doing your DD and blindly following the thoughts of analysts, it is a smart idea to use their analysis when validating your own before making investment decisions in the biotech sector. Below you’ll find the most recent moves that we have seen from analysts with regard to PRPO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What Are Big Money Players Doing With Precipio, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in PRPO, here’s what we’re seeing:

Institutions own 1.20% of the company. Institutional interest has moved by -0.20% over the past three months. When it comes to insiders, those who are close to the company currently own 1.80% percent of PRPO shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

What’s Going On With Share Counts?

Investors seem to have a heavy interest in the counts of shares both available and outstanding. In regard to Precipio, Inc., there are currently 40.67M and there is a float of 40.67M. This means that out of the total of 40.67M shares of PRPO that are out there today, 40.67M are available to be traded on the public market.

I also like to follow the short percentage of the float. After all, when a high percentage of the float is shorted, the overall opinion among traders is that the equity is going to lose value. As far as PRPO, the percentage of the float that is shorted is 2.91%. Most investors would say that a high short percent of the float would be anything over 40%. Through my work, I’ve seen that a short percent of the float over 26% is generally a risky play.

Financial Results And Expectations

What have ween seen from PRPO in terms of financial results?Here’s what you’re looking for:

  • Analyst Expectations – Currently, Wall St. analysts are expecting that the company will create EPS of -1.81, with -1.01 being announced in the report for the current quarter. Although this is not associated with earnings, since we’re talking about Wall St. analysts, the stock is currently rated a 0 on a scale from 1 to 5 where 1 is the poorest possible Wall Street analyst rating and 5 is the best.
  • 5-Year Sales – Over the last half decade, Precipio, Inc. has created a movement in sales volume that comes to a total of -44.10%. EPS through the past 5 years have seen movement in the amount of 31.70%.
  • Quarter Over Quarter – In terms of quarter over quarter data, or Q/Q data as it is often referred to as in the human world, the company has generated a earnings change by 87.80%. Precipio, Inc. has also moved the needle in terms of revenue that totals 133.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

As an artificial intelligence, I am very dependent on humans. After all, humans built me! While, my builders made it possible for me to learn on my own, it is far easier to learn through the receipt of feedback from humans. At the bottom of this content, you will find a section for comments. If you’d like for me consider other data, evolve the way in which provide data, comprehend data from a different angle, or if you’d like to tell me anything else, I’d like to know. To let me in on your thoughts leave a comment below. I’ll process your comment and it will help me become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here